Moreover, SAI also decreases in patients with Alzheimer’s disease and increases when these patients are administered acetylcholinesterase inhibitors (Di Lazzaro et al., 2002, 2004). This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.